ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

AVXL Anavex Life Sciences Corporation

4.03
0.01 (0.25%)
Última actualización: 08:36:44
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Anavex Life Sciences Corporation AVXL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.01 0.25% 4.03 08:36:44
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.00 3.99 4.06 4.02
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/5/202406:30GLOBEAnavex Life Sciences Announces Expansion of Leadership Team
17/5/202405:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202406:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 2nd..
10/5/202404:45PRNUSShareholders that lost money on Anavex Life Sciences..
09/5/202415:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202407:00EDGAR2Form 8-K - Current report
09/5/202406:30GLOBEAnavex Life Sciences Reports Fiscal 2024 Second Quarter..
07/5/202404:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
06/5/202405:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/5/202404:45PRNUSAnavex Life Sciences Corporation Sued for Securities Law..
02/5/202406:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 Second Quarter..
26/4/202404:45PRNUSMay 13, 2024 Deadline: Contact The Gross Law Firm to Join..
19/4/202404:45PRNUSContact The Gross Law Firm by May 13, 2024 Deadline to Join..
16/4/202404:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
12/4/202404:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
11/4/202406:30GLOBEAnavex Life Sciences to Present at the Noble Capital Markets..
09/4/202404:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
05/4/202404:45PRNUSAnavex Life Sciences Corporation Class Action: The Gross Law..
02/4/202404:45PRNUSShareholders that lost money on Anavex Life Sciences..
29/3/202404:45PRNUSLost Money on Anavex Life Sciences Corporation(AVXL)? Join..
26/3/202404:45PRNUSInvestors who lost money on Anavex Life Sciences..
25/3/202406:30GLOBEAnavex Life Sciences to Present at the 23rd Annual Needham..
22/3/202404:45PRNUSAVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life..
18/3/202406:30GLOBEAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase..
26/2/202406:30GLOBEAnavex Life Sciences to Present at the 44th Annual TD Cowen..
23/2/202405:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202405:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202405:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202405:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202405:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202406:30GLOBEAnavex Life Sciences Reports Fiscal 2024 First Quarter..
01/2/202406:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 First Quarter..
25/1/202416:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202406:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
16/1/202406:30GLOBEAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial..
12/1/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202406:30GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
03/1/202406:30GLOBEAnavex to Present at the 42nd Annual J.P. Morgan Healthcare..
02/1/202407:00GLOBEAnavex Life Sciences Provides an Update on Rett Syndrome..
20/12/202306:30GLOBEAnavex Announces First Entire Clinical Gene Pathway Data of..
19/12/202306:30GLOBEAnavex Received Agreement from the Committee for Medicinal..
27/11/202315:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/11/202307:00GLOBEAnavex Life Sciences Reports Fiscal 2023 Year End Financial..
27/11/202305:29IHMARKETNEWSMonday’s Wall Street Highlights: Walmart, Disney, Lloyds..
24/11/202307:00GLOBEAnavex Life Sciences to Announce Fiscal 2023 Year End..
22/11/202307:00GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
20/11/202307:00GLOBEAnavex Initiates Regulatory Submission of Oral Blarcamesine..
06/11/202307:00GLOBEAnavex Life Sciences Appoints Senior VP of Regulatory..
25/10/202307:00GLOBEAnavex Life Sciences Reports New Publication in Scientific..